AlphAIAlphAI — Financial news for AI agents
globenewswire.comOCT 61 min read$MMSI

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

Merit Medical Systems (MMSI) will release Q3 2026 financial results on October 29, 2026, after market close, followed by an investor conference call at 4:30 p.m. ET. The company develops and distributes medical devices for various procedures, employing about 7,500 people globally.

Original reporting
globenewswire.com
Published Oct 6, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$MMSI
Neutral
medium confidence
Mentioned
$MMSI
Relevance
5/10
AlphAI data visualization · based on globenewswire.com
Decision brief

The 30-second read

$MMSINeutralLow
01

Why it matters

The announcement of the earnings release date provides a clear timeline for traders to position ahead of the report, but without guidance or numbers the immediate actionable insight is limited.

02

Market read

The news is relevant for traders focusing on healthcare stocks and earnings-driven volatility.

03

What to watch

Potential regulatory or supply-chain developments that could influence results but are not mentioned.

Relevance 5/10Novelty 5/10Timing: pre-market on Oct 29, 2026

Background

Merit Medical Systems is a U.S.-listed medical device company that provides products for interventional, diagnostic, and therapeutic procedures.

Company-level read

Ticker impact

$MMSINeutralMedium confidence
Context

Merit Medical announced it will release its Q3 2026 results on October 29, 2026.

Expected impact

potential pressure as the market prices in earnings expectations

Evidence & confidence

No earnings numbers are provided yet, but the announcement of the release date is new information that can affect trading around the event.

Market effects

Sector

May affect the broader medical device sector as investors assess Merit Medical's performance relative to peers.

Regional

Limited to U.S. markets where the stock trades.

Global

Minimal global impact beyond investors tracking U.S. healthcare stocks.

Counterpoint

What could challenge this read

If the market expects strong growth, the earnings could disappoint, leading to a sell-off.

Key entities

  • company
    Merit Medical Systems, Inc.

    Medical device manufacturer (NASDAQ:MMSI).

Read at source← All news

Related articles

AUG 12
$MMSIMedAI 8/10

Merit Medical Systems (MMSI) Is Up 6.2% After Raising 2026 Outlook And Q2 Beat Expectations – Has The Bull Case Changed?

Merit Medical Systems (MMSI) reported Q2 2026 sales of $418.84 million and net income of $38.8 million, and raised its full-year 2026 revenue outlook to $1.63 billion to $1.64 billion, according to the company. The article notes ongoing product recalls and reimbursement risks and mentions a 2029 narrative of about $1.8 billion revenue and $213.7 million earnings.

simplywall.st6 min
AUG 9
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

aol.com6 min
AUG 8
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

fool.com6 min
JUL 31
$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

benzinga.com3 min
JUL 30
$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

financialcontent.com4 min